Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

BCHT May 13, 2026

Birchtech Q1 2026 Earnings Call - Judgment Collection and Water Pivot Drive Revenue Growth

Birchtech reported Q1 2026 revenue of $4.2M, up 32% YoY, driven by a shift from one-time licensing fees to recurring product supply in its air business and new water treatment projects. The company ra...

  • Revenue surged 32% to $4.2M in Q1 2026, marking a decisive shift from upfront licensing fees to recurring product supply revenue.
  • The company raised $16.4M through a NYSE American uplisting, significantly bolstering its balance sheet and investor base.
  • Enforcement of a $78M patent infringement judgment is underway, with asset discovery and collection efforts ramping up post-appeal.
  • +7 more takeaways
LESL May 13, 2026

Leslie's Q2 FY2026 Earnings Call - Price Drop Strategy Drives Customer Growth and Margin Expansion

Leslie’s delivered a transformative Q2 FY2026, with revenue rising 4.3% to $184.7 million and comparable sales jumping 6.6%. The company’s Price Drop initiative, launched in March, successfully reacti...

  • Revenue grew 4.3% year-over-year to $184.7 million, outpacing expectations and driven by strong residential and Pro sales.
  • Comparable sales increased 6.6%, with double-digit growth in transactions and a 350 basis point improvement in conversion rates following the Price Drop launch.
  • Gross profit margin expanded to 28.9% from 24.8% in the prior year, aided by higher sales volume leverage, favorable occupancy costs, and reduced inventory reserves.
  • +7 more takeaways
MSGM May 13, 2026

Motorsport Games Q1 2026 Earnings Call - Player Growth and Recurring Revenue Surge

Motorsport Games reported a strong Q1 2026, driven by a 129% year-over-year revenue increase to $4 million, fueled by surging player engagement in Le Mans Ultimate and accelerating recurring revenue f...

  • Revenue surged 129% year-over-year to $4.0 million, driven by $1.6 million in Le Mans Ultimate sales growth and $0.7 million in RaceControl subscription growth.
  • Le Mans Ultimate hit a new all-time peak of 8,800 concurrent players on Steam, with average concurrent users growing 169% year-over-year, indicating strong player retention.
  • RaceControl subscription revenue exceeded $0.2 million monthly, now comprising 19% of total Q1 revenue, up from 6% in Q1 2025, highlighting a shift toward recurring, high-margin income.
  • +7 more takeaways
GO May 13, 2026

Grocery Outlet Q1 2026 Earnings Call - Traffic Stabilizes as Management Pivots to Opportunistic Product Mix

Grocery Outlet reported Q1 2026 revenue of $1.17 billion, up 3.6% year-over-year, with comparable store sales down 1%. The decline was driven by a 3.1% drop in average transaction size, partially offs...

  • Revenue grew 3.6% to $1.17 billion, exceeding the low end of prior guidance despite a 1% decline in comparable store sales.
  • Comparable store sales declined 1%, driven by a 3.1% drop in average transaction size, which was partially offset by a 2.1% increase in traffic.
  • Traffic showed sequential improvement throughout Q1, exiting March with a 2-5% year-over-year growth rate, indicating early stabilization.
  • +7 more takeaways
USAR May 13, 2026

USA Rare Earth Q1 2026 Earnings Call - Securing Western Supply Chains With $3.6B Brazil Deal And $1.6B Government Funding

USA Rare Earth is pivoting from a development-stage project to a fully integrated global rare earth platform. The company announced three critical transactions: the acquisition of Serra Verde Group fo...

  • Acquisition of Serra Verde Group for $3.64 billion secures the Pela Ema mine in Brazil, the only scaled producer of all four magnetic rare earths outside of Asia.
  • Serra Verde includes a 15-year offtake agreement with a U.S. government-financed SPV featuring price floors for NdPr, dysprosium, and terbium, providing transparent price signals.
  • Strategic investment in Carester amplifies global leadership in heavy rare earth processing and grants access to world-class engineering capabilities and IP.
  • +11 more takeaways
WATT May 13, 2026

Energous Wireless Power Solutions Q1 2026 Earnings Call - Fortune 10 Deployments Drive Revenue Surge and Margin Expansion

Energous Wireless Power Solutions reported a 51% year-over-year improvement in net loss for Q1 2026, with revenue jumping to $3.1 million from $0.3 million in the prior year period. The company highli...

  • Revenue surged to $3.1 million in Q1 2026, up 933% year-over-year from $0.3 million, marking the fifth consecutive quarter of revenue growth.
  • Net loss improved 51% year-over-year to $1.7 million, from $3.4 million in Q1 2025, as gross margin expanded to 36% from 27%.
  • Gross margin expansion was driven by higher volume shipments of the PowerBridge Pro transmitter, which has achieved zero returns since commercial production began in 2024.
  • +7 more takeaways
OMER May 13, 2026

Omeros Corporation Q1 2026 Earnings Call - YARTEMLEA Launch Drives Strong Early Uptake and Cash Flow Positivity

Omeros Corporation delivered a robust first quarter 2026, driven by the successful launch of YARTEMLEA, the first and only approved treatment for TA-TMA. The company reported $11.1 million in gross re...

  • YARTEMLEA launched in mid-January 2026, generating $11.1 million in gross revenues and $9.9 million in net revenues in Q1 2026, with gross-to-net adjustments held to a modest 11%.
  • The company achieved cash flow positivity in the first quarter, just weeks after launch, and projects company-wide positive cash flow within 18 months.
  • Adoption is accelerating ahead of plan: 30 unique accounts ordered YARTEMLEA by March 31, with 60% of the top 10 U.S. transplant centers securing P&T committee approvals.
  • +7 more takeaways
BEAT May 13, 2026

HeartBeam Q1 2026 Earnings Call - Lean Commercial Rollout and Cash Runway Extended

HeartBeam is executing a capital-efficient, lean commercial rollout of its cable-free synthesized 12-lead ECG, securing anchor accounts in four key U.S. markets and validating a premium subscription m...

  • HeartBeam secured its first commercial partnership with ClearCardio, establishing a presence in New York City, Dallas, and South Florida, and later added Atelier Health in Beverly Hills to cover Southern California.
  • The company’s premium subscription model is priced between $750 and $1,000 annually, with early physician feedback indicating strong demand for the clinical-grade 12-lead ECG capability.
  • HeartBeam is executing a lean commercial strategy, using a small team to validate the business model in four key geographies before scaling sales and clinical support in the second half of 2026.
  • +7 more takeaways
MCHX May 13, 2026

Marchex Q1 2026 Earnings Call - Archenia Acquisition and AI Bundling Drive EBITDA Upgrade

Marchex reported a slight sequential revenue decline to $10.6 million in Q1 2026, but management pivoted sharply toward a higher-growth narrative centered on its pending Archenia acquisition and AI-dr...

  • Revenue dipped slightly to $10.6 million in Q1 2026, down from $10.8 million in Q4 2025, due to legacy platform migration offsets partially masked by new sales and upsells.
  • Management announced a significant EBITDA upgrade, guiding Q2 adjusted EBITDA to $1.6–$1.8 million, up from prior guidance of >$1 million.
  • Standalone Q3 2026 adjusted EBITDA is now projected at $2 million or more, with combined Archenia EBITDA potentially reaching $2.5 million if the deal closes.
  • +7 more takeaways
CTSO May 13, 2026

CytoSorbents Q1 2026 Earnings Call - DrugSorb-ATR FDA Pathway Clarified Amidst Geopolitical Headwinds

CytoSorbents reported a 2% year-over-year revenue increase to $8.9 million in Q1 2026, driven by strong 13% growth in direct international sales outside Germany, which was partially offset by a declin...

  • Q1 2026 revenue reached $8.9 million, marking a 2% year-over-year increase, though this was down 7% on a constant currency basis.
  • Direct international sales outside Germany grew 13% year-over-year, highlighting improved physician awareness and execution in new markets.
  • German market sales declined year-over-year, but management reports improved sales force productivity and plans to selectively rebuild the team to drive future growth.
  • +11 more takeaways